A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic Surgery

Sponsor
The Cleveland Clinic (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03413449
Collaborator
(none)
360
1
65.7
5.5

Study Details

Study Description

Brief Summary

The purpose of this study is to develop an all-encompassing frailty model using laboratory and functional studies. A frailty model will help us determine prior to surgery who will require rehabilitation and skilled nursing needs beyond discharge. This model will also help us determine who will likely be readmitted and why they will be readmitted. Understanding these things can help us prevent some of them from occurring in the future.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Frailty model

Detailed Description

Frailty is a widely accepted but poorly defined physical condition that has been shown to be an independent predictor of surgical morbidity and direct discharge to skilled nursing facility (SNF). Attempts have been made to study frailty in surgical patients by employing models designed for the general population. Despite the attempts of studying frailty in general surgery patients, no study has designed a model comprised of objective metrics for general thoracic surgery patients.

The purpose of this study is to better understand frailty in the context of thoracic surgery patients and to develop an objective model of this nebulous variable. It is hoped that standard, simple, functional and laboratory data can be used to construct the model with the goal being to determine the impact of frailty on outcome for patients undergoing esophagectomy, lobectomy, or pneumonectomy. If a preoperative frailty index can be developed and demonstrated to predict outcome, this scoring system may allow care teams to predict post-operative complications, ICU and hospital recidivism, and early mortality, and possibly allow for much earlier preparation for unfavorable outcomes.

Study Design

Study Type:
Observational
Actual Enrollment :
360 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic Surgery
Actual Study Start Date :
Jan 8, 2018
Actual Primary Completion Date :
Jul 2, 2019
Anticipated Study Completion Date :
Jul 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Resections

Frailty model for patients undergoing esophagectomy and pneumonectomy/lobectomy for cancer

Diagnostic Test: Frailty model
Grip strength 30 second chair sit stand test Psoas muscle area Six minute walk

Outcome Measures

Primary Outcome Measures

  1. Morbidity [Assessed at discharge and will be reported through study completion, an average of 1 year]

    Number of STS defined complications (chest tube airleak, atelectasis, pleural effusion requiring drain, pneumonia, ARDS, respiratory failure, bronchopleural fistula, PE, pneumothorax, chylothorax, ventilator > 48 hours, tracheostomy, tracheobronchial injury, ileus, anastomotic leak, GI dilation, conduit necrosis requiring surgery, delayed conduit emptying, C. diff, delirium) will be combined to report the number of morbidity events

  2. Discharge status [Assessed at discharge and will be reported through study completion, an average of 1 year]

    Discharge destination

Secondary Outcome Measures

  1. Length of stay [Assessed from date of surgery until the date of discharge and will be reported through study completion, an average of 1 year]

    Time spent in the hospital during perioperative stay

  2. 30 day readmission [Assessed from date of discharge to thirty days after discharge and will be reported through study completion, an average of 1 year]

    If a patient requires a readmission to the hospital within 30 days of discharge and the reasons for readmission

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients >18 years old who are undergoing pneumonectomy, lobectomy or esophagectomy with a cancer diagnosis over a 1-year enrollment.
Exclusion Criteria:
  • Patients who are unable to sign a consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cleveland Clinic Foundation Cleveland Ohio United States 44195

Sponsors and Collaborators

  • The Cleveland Clinic

Investigators

  • Principal Investigator: Sudish Murthy, MD, PhD, The Cleveland Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sudish Murthy, Principal Investigator, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT03413449
Other Study ID Numbers:
  • 17-1708
First Posted:
Jan 29, 2018
Last Update Posted:
Oct 1, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 1, 2021